The prevalence of TERT promoter mutations was significantly different according to the underlying liver disease, with the highest frequency in HCV-related HCC (44%) followed by non-viral (38%) and HBV-related HCC (23%). The gene discussed is TERT; the disease is hepatocellular carcinoma.